PharmacoEconomics - open

· 2 papers in corpus

2026

Cost-Effectiveness of Follitropin Delta Compared with Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in France.

doi:10.1007/s41669-026-00641-2 ·PMID:41811581

BackgroundFollitropin delta, using a personalized dosing regimen, is an effective treatment option for women undergoing controlled ovarian stimulation (COS) for in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI).ObjectiveT…

2023

Healthcare Costs Before and After Diagnosis of Cancer of Unknown Primary Versus Ovarian Cancer in Australia.

doi:10.1007/s41669-022-00371-1 ·PMID:36253664

BackgroundLittle is known about the healthcare resource usage and costs for patients with cancer of unknown primary (CUP).ObjectiveThe aim of this study was to describe and quantify healthcare resource use and costs in Australia, 6 months p…